Looking at the predictions and corresponding evidence chains in Fig. 4b, Cabergoline is suggested as a potential treatment for the disease, mainly due to its link with hyperprolactinemia and the JAK/STAT signalling pathway. The gene discussed is SOAT1; the disease is hyperprolactinemia.